Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: elepet who wrote (20862)	2/21/2000 3:27:00 PM
From: ~digs	Respond to of 57584

<<<What is proteinomics?>>> I will defer that question to Mr. Buskey. He's offered some great links a few posts back that should help clear things up. With regards to TCLN... a closer look reveals that it is not really a protein play IMO... and I have removed it from that watchlist. That does not mean it's not a great company with good prospects... perhaps it should be included in a Cancer Detection/Therapy basket? (I'm working on it.) <<<Personal dilemma: whether to sell some and profit now, buy more , or do nothing and hold what I've got for long term.>>> My novice opinion: TCLN has a nice uptrend going... but it looks like a good short play for the immediate term. Maybe look for reentry near 5 1/2? On the other hand... it would not surpise me if TCLN (along with many other biotechs) kept running for slightly longer. I suggest keeping your ear to the ground monitoring the biotech buzz (or lack thereof)... I think some of these small issues could get really hammered once the sector settles down a bit. If your cost basis is rather cheap... consider a dose of ProfitOften. Hope this helps...